91ÖÆƬ³§

Published on Market Research Reports® Inc. ()

Home > Global Peripheral Blood Mononuclear Cells (PBMC) Market Research Report 2025

Global Peripheral Blood Mononuclear Cells (PBMC) Market Research Report 2025

Publication ID: 
PB503252944
Publication Date: 
March 6, 2025
Pages: 
64
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Specialty Chemicals [2]
Manufacturing (Chemicals) [3]
Chemicals [4]
Description: 

The global market for Peripheral Blood Mononuclear Cells (PBMC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Peripheral Blood Mononuclear Cells (PBMC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Blood Mononuclear Cells (PBMC).
The Peripheral Blood Mononuclear Cells (PBMC) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Blood Mononuclear Cells (PBMC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Blood Mononuclear Cells (PBMC) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
STEMCELL Technologies
Zen-Bio
ATCC
AllCells
Segment by Type
≥ 50 Million Cells
Other
Segment by Application
ELISPOT
Proliferation Assays
Immunogenicity Assays
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Blood Mononuclear Cells (PBMC) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ≥ 50 Million Cells
1.2.3 Other
1.3 Market by Application
1.3.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 ELISPOT
1.3.3 Proliferation Assays
1.3.4 Immunogenicity Assays
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Perspective (2020-2031)
2.2 Global Peripheral Blood Mononuclear Cells (PBMC) Growth Trends by Region
2.2.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Region (2020-2025)
2.2.3 Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Region (2026-2031)
2.3 Peripheral Blood Mononuclear Cells (PBMC) Market Dynamics
2.3.1 Peripheral Blood Mononuclear Cells (PBMC) Industry Trends
2.3.2 Peripheral Blood Mononuclear Cells (PBMC) Market Drivers
2.3.3 Peripheral Blood Mononuclear Cells (PBMC) Market Challenges
2.3.4 Peripheral Blood Mononuclear Cells (PBMC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Revenue
3.1.1 Global Top Peripheral Blood Mononuclear Cells (PBMC) Players by Revenue (2020-2025)
3.1.2 Global Peripheral Blood Mononuclear Cells (PBMC) Revenue Market Share by Players (2020-2025)
3.2 Global Peripheral Blood Mononuclear Cells (PBMC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peripheral Blood Mononuclear Cells (PBMC) Revenue
3.4 Global Peripheral Blood Mononuclear Cells (PBMC) Market Concentration Ratio
3.4.1 Global Peripheral Blood Mononuclear Cells (PBMC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Blood Mononuclear Cells (PBMC) Revenue in 2024
3.5 Global Key Players of Peripheral Blood Mononuclear Cells (PBMC) Head office and Area Served
3.6 Global Key Players of Peripheral Blood Mononuclear Cells (PBMC), Product and Application
3.7 Global Key Players of Peripheral Blood Mononuclear Cells (PBMC), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Blood Mononuclear Cells (PBMC) Breakdown Data by Type
4.1 Global Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Type (2020-2025)
4.2 Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Type (2026-2031)
5 Peripheral Blood Mononuclear Cells (PBMC) Breakdown Data by Application
5.1 Global Peripheral Blood Mononuclear Cells (PBMC) Historic Market Size by Application (2020-2025)
5.2 Global Peripheral Blood Mononuclear Cells (PBMC) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
6.2 North America Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025)
6.4 North America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
7.2 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025)
7.4 Europe Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
8.2 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2020-2025)
8.4 Asia-Pacific Peripheral Blood Mononuclear Cells (PBMC) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
9.2 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025)
9.4 Latin America Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size (2020-2031)
10.2 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2020-2025)
10.4 Middle East & Africa Peripheral Blood Mononuclear Cells (PBMC) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.1.4 Lonza Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 STEMCELL Technologies
11.2.1 STEMCELL Technologies Company Details
11.2.2 STEMCELL Technologies Business Overview
11.2.3 STEMCELL Technologies Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.2.4 STEMCELL Technologies Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.2.5 STEMCELL Technologies Recent Development
11.3 Zen-Bio
11.3.1 Zen-Bio Company Details
11.3.2 Zen-Bio Business Overview
11.3.3 Zen-Bio Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.3.4 Zen-Bio Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.3.5 Zen-Bio Recent Development
11.4 ATCC
11.4.1 ATCC Company Details
11.4.2 ATCC Business Overview
11.4.3 ATCC Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.4.4 ATCC Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.4.5 ATCC Recent Development
11.5 AllCells
11.5.1 AllCells Company Details
11.5.2 AllCells Business Overview
11.5.3 AllCells Peripheral Blood Mononuclear Cells (PBMC) Introduction
11.5.4 AllCells Revenue in Peripheral Blood Mononuclear Cells (PBMC) Business (2020-2025)
11.5.5 AllCells Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned: 

Lonza
STEMCELL Technologies
Zen-Bio
ATCC
AllCells

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-peripheral-blood-mononuclear-cells-pbmc-market-research-report-2025

Links
[1] /countries/global[2] /specialty-chemicals[3] /manufacturing-chemicals[4] /chemicals